1832 Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-130,300
Closed -$8.84M 870
2023
Q1
$8.84M Buy
+130,300
New +$8.38M 0.01% 364
2021
Q1
Sell
-846,000
Closed -$113M 723
2020
Q4
$113M Buy
+846,000
New +$102M 0.27% 100
2019
Q4
Sell
-1,056,600
Closed -$96M 687
2019
Q3
$96M Buy
1,056,600
+395,100
+60% +$45M 0.31% 79
2019
Q2
$74.4M Buy
661,500
+87,500
+15% +$8.82M 0.24% 98
2019
Q1
$47.6M Buy
+574,000
New +$48.9M 0.16% 126

Other funds holding EXAS

1832 Asset Management's EXAS Position: Q2 2023 in Review

1832 Asset Management sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 130,300 shares — an estimated $8.84M sold.

1832 Asset Management first reported a position in EXAS in Q1 2019 and held it in 5 quarters. The position peaked at $113M in Q4 2020. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • 1832 Asset Management reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • 1832 Asset Management sold 130,300 Exact Sciences shares in Q2 2023, an estimated $8.84M.
  • 1832 Asset Management first reported a position in Exact Sciences in Q1 2019 and held it in 5 quarters.
  • 1832 Asset Management's Exact Sciences position peaked at $113M in Q4 2020.
  • 654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on 1832 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.